Ages of onset of mood and anxiety disorders in fragile x premutation carriers

Current Psychiatry Reviews

Volumn 9, Issue 1, 2013, Pages 65-71

  Seritan, Andreea L ^a,b   Bourgeois, James A ^c   Schneider, Andrea ^a,b   Mu, Yi ^d   Hagerman, Randi J ^a,b   Nguyen, Danh V ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety; Depression; FMR1 premutation; Fragile X tremor ataxia syndrome (FXTAS); Mdd; Onset age

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; ATAXIA; CONTROLLED STUDY; DSM-IV; FEMALE; GENE MUTATION; GENERALIZED ANXIETY DISORDER; HETEROZYGOTE; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MINI MENTAL STATE EXAMINATION; MOOD DISORDER; ONSET AGE; PANIC; PHOBIA; PRIORITY JOURNAL; SOCIAL PHOBIA; STRUCTURED INTERVIEW; TREMOR;

EID: 84875320330     PISSN: 15734005     EISSN: 18756441     Source Type: Journal    
DOI: 10.2174/157340013805289662     Document Type: Article

References (61)

1. Hagerman PJ.The fragile X prevalence paradox.J Med Genet 2008; 45: 498-499.
2. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ.Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in fragile X syndrome.Am J Hum Genet 2000; 66: 6-15.
3. Greco C, Berman RF, Martin RM, et al Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS).Brain 2006; 129: 243-255.
4. Greco CM, Soontrapornchai K, Wirojanan J, Gould JE, Hagerman PJ, Hagerman RJ.Testicular and pituitary inclusion formation in fragile X associated tremor/ataxia syndrome.J Urol 2007; 177: 1434-1437.
5. Hunsaker MR, Greco CM, Spath MA, et al Widespread noncentral nervous system organ pathology in fragile X premutation carriers with fragile X-associated tremor/ataxia syndrome and CGG knock-in mice.Acta Neuropathol 2011; 122: 467-479.
6. Hagerman RJ, Leehey M, Heinrichs W, et al Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X.Neurology 2001; 57: 127-130.
7. Jacquemont S, Hagerman RJ, Leehey M, et al Fragile X premutation tremor/ataxia syndrome: Molecular, clinical, and neuroimaging correlates.Am J Hum Genet 2003; 72: 869-878.
8. Jacquemont S, Hagerman RJ, Leehey MA, et al Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.JAMA 2004; 291: 460-469.
9. Coffey SM, Cook K, Tartaglia N, et al Expanded clinical phenotype of women with the FMR1 premutation.Am J Med Genet 2008; 146: 1009-1016.
10. Rodriguez-Revenga L, Madrigal I, Pagonabarraga J, et al Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families.Eur J Hum Genet 2009; 17: 1359-1362.
11. Leehey MA, Berry-Kravis E, Min SJ, et al Progression of tremor and ataxia in male carriers of the FMR1 premutation.Mov Disord 2007; 22: 203-206.
12. Seritan AL, Nguyen DV, Farias ST, et al Dementia in fragile Xassociated tremor/ataxia syndrome (FXTAS): Comparison with Alzheimer's disease.Am J Med Genet B Neuropsychiatr Genet 2008; 147B: 1138-1144.
13. Hagerman RJ, Leavitt BR, Farzin F, et al Fragile X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation.Am J Hum Genet 2004; 74: 1051-1056.
14. Chonchaiya W, Nguyen DV, Au J, et al Clinical involvement in daughters of men with fragile X-associated tremor ataxia syndrome.Clin Genet 2010; 78: 38-46.
15. Leehey MA, Legg W, Tassone F, Hagerman RJ.Fibromyalgia in fragile X mental retardation 1 gene premutation carriers.Rheumatology 2011; 50: 2233-2236.
16. Hessl D, Tassone F, Loesch DZ, et al Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation.Am J Med Genet B Neuropsychiatr Genet 2005; 139B: 115-121.
17. Bourgeois JA, Cogswell JB, Hessl D, et al Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome.Gen Hosp Psychiatry 2007; 29: 349-356.
18. Roberts JE, Bailey D, Mankowski J, et al Mood and anxiety disorders in females with the FMR1 premutation.Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 130-139.
19. Rodriguez-Revenga L, Madrigal I, Alegret M, Santos M, Milà M.Evidence of depressive symptoms in fragile-X syndrome premutated females.Psychiatr Genet 2008; 18: 153-155.
20. Bourgeois JA, Seritan AL, Casillas EM, et al Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers.J Clin Psychiatry 2011; 72: 175-182.
21. Bacalman S, Farzin F, Bourgeois JA, et al Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia.J Clin Psychiatry 2006; 67: 87-94.
22. Bourgeois JB, Farzin F, Brunberg JA, et al Dementia with mood symptoms in a carrier of the fragile X-associated tremor/ataxia syndrome (FXTAS): clinical intervention with donepezil and venlafaxine.J Neuropsychiatry Clin Neurosci 2006; 18: 171-177.
23. Grigsby J, Brega AG, Jacquemont S, et al Impairment in the cognitive functioning of men with fragile X-associated tremor/ataxia syndrome (FXTAS).J Neurol Sci 2006; 248: 227-233.
24. Grigsby J, Brega AG, Leehey MA, et al Impairment of executive cognitive functioning in males with fragile X-associated tremor/ataxia syndrome.Mov Disord 2007; 22: 645-650.
25. Brega AG, Goodrich G, Bennett RE, et al The primary cognitive deficit among males with fragile X-associated tremor/ataxia syndrome (FXTAS) is a dysexecutive syndrome.J Clin Exp Neuropsychol 2008; 30: 853-869.
26. Al-Hinti JT, Nagan N, Harik SI.Fragile X premutation in a woman with cognitive impairment, tremor, and history of premature ovarian failure.Alzheimer Dis Assoc Disord 2007; 21: 262-264.
27. Karmon Y, Gadoth N.Fragile X associated tremor/ataxia syndrome (FXTAS) with dementia in a female harbouring FMR1 premutation.J Neurol Neurosurg Psychiatry 2008; 79: 738-739.
28. Rodriguez-Revenga L, Pagonabarraga J, Gomez-Anson B, et al Motor and mental dysfunction in mother-daughter transmitted FXTAS.Neurology 2010; 75: 1370-1376.
29. Yachnis AT, Roth HL, Heilman KT.Fragile X dementia parkinsonism syndrome (FXPDS).Cogn Behav Neurol 2010; 23: 39-43.
30. Gane LW, Iosif AM, Flynn-Wilson L, Venturino M, Hagerman RJ, Seritan AL.Assessment of patient and caregiver needs in fragile Xassociated tremor/ataxia syndrome (FXTAS) by utilizing Q-sort methodology.Aging Ment Health 2010; 14: 1000-1007.
31. First MB, Spitzer RL, Gibbon M, Williams JBW.Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P).New York: Biometrics Research, New York State Psychiatric Institute, November 2002.
32. American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision.Washington (DC): American Psychiatric Association, 2000.
33. Hagerman PJ, Hagerman RJ.Fragile X-associated tremor/ataxia syndrome (FXTAS).Ment Retard Dev Disabil Res Rev 2004; 10: 25-30.
34. Wechsler D.Wechsler Adult Intelligence Scale-Third Edition: Administration and Scoring Manual.San Antonio, Harcourt Asessment Inc., 1997.
35. Folstein M, Folstein S, McHugh P.Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician.J Psych Research 1975; 12: 189-198.
36. Tassone F, Pan R, Amiri K, Taylor AK, Hagerman PJ.A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.J Mol Diagn 2008; 10: 43-49.
37. Mattisson C, Bogren M, Horstmann V, Munk-Jörgensen P, Nettelbladt P.The long-term course of depressive disorders in the Lundby Study.Psychol Med 2007; 37: 883-891.
38. Eaton WW, Shao H, Nestadt G, Lee HB, Bienvenu OJ, Zandi P.Population-based study of first onset and chronicity in major depressive disorder.Arch Gen Psychiatry 2008; 65: 513-520.
39. Altamura AC, Buoli M, Albano A, Dell'Osso B.Age at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: A naturalistic study.Int Clin Psychopharmacol 2010; 25: 172-179.
40. Trumpf J, Margraf J, Vriends N, Meyer AH, Becker ES.Specific phobia predicts psychopathology in young women.Soc Psychiatry Psychiatr Epidemiol 2010; 45: 1161-1166.
41. Epidemiologic Catchment Area Study.Available from: http://www.icpsr.umich.edu/icpsrweb/ICPSR/studies/06153
42. National Comorbidity Survey Replication.Available from: http://www.hcp.med.harvard.edu/ncs
43. Stinson FS, Dawson DA, Chou PS, et al The epidemiology of DSM-IV specific phobia in the USA: Results from the National Epidemiologic Survey on Alcohol and Related Conditions.Psychol Med 2007; 37: 1047-1059.
44. Vesga-Lopez O, Schneier FR, Wand S, et al Gender differences in generalized anxiety disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).J Clin Psychiatry 2008; 69: 1606-1616.
45. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters E.Lifetime prevalence and age-of-onset distributions in the National Comorbidity Survey Replication.Arch Gen Psychiatry 2005; 62: 593-602.
46. Kessler RC, Chui WT, Jin R, Ruscio AM, Shear K, Walters E.The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication.Arch Gen Psychiatry 2006; 63: 415-424.
47. Pine DS, McClure EB.Anxiety disorders: Clinical features.In: Sadock BJ, Sadock VA, editors.Comprehensive Textbook of Psychiatry, 8th ed.Philadelphia: Lippincott Williams & Wilkins 2005; pp.1768-1773.
48. Knappe S, Beesdo-Baum K, Fehm L, Stein MB, Lieb R, Wittchen HU.Social fear and social phobia types among community youth: Differential clinical features and vulnerability factors.J Psychiatr Res 2011; 45: 111-120.
49. Hochberg Y.A Sharper Bonferroni procedure for multiple significance testing.Biometrika 1988; 75: 800-803.
50. Ross CA, Tabrizi SJ.Huntington's disease: from molecular pathogenesis to clinical treatment.Lancet Neurol 2011; 10: 83-98.
51. Orth M, Handley OJ, Schwenke C, et al Observing Huntington's disease: the European Huntington's Disease Network's Registry.PLoS Curr 2010 Sep 28
52. Hashimoto R, Srivastava S, Tassone F, Hagerman RJ, Rivera SM.Diffusion tensor imaging in male premutation carriers of the fragile X mental retardation gene.Mov Disord 2011; 26: 1329-1336.
53. Seritan AL, Schneider A, Olichney JM, Leehey MA, Akins RS, Hagerman RJ.Conversion disorder in women with the FMR1 premutation.Am J Med Genet 2009; 149: 2501-2506.
54. Zhang L, Coffey S, Lua LL, et al FMR1 premutation in females diagnosed with multiple sclerosis.J Neurol Neurosurg Psychiatry 2009; 80: 812-814.
55. Haussleiter IS, Brüne M, Juckel G.Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.Ther Adv Neurol Disord 2009; 2: 13-29.
56. Lo Fermo S, Barone R, Patti F, et al Outcome of psychiatric symptoms presenting at onset of multiple sclerosis: a retrospective study.Mult Scler 2010; 16: 742-78.
57. Kessler RC, Berglund P, Demler O, et al The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R).JAMA 2003; 289: 3095-3105.
58. Bailey DB, Sideris J, Roberts J, Hatton D.Child and genetic variables associated with maternal adaptation to fragile X syndrome: A multidimensional analysis.Am J Med Genet 2008; 146A: 720-729.
59. Perlis TE, Des Jarlais DC, Friedman SR, Arasteh K, Turner CF.Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs.Addiction 2004; 99: 885-896.
60. Buckley B.It's the way you ask that matters: comparison of data relating to prevalence of incontinence aid use from two surveys of people with multiple sclerosis.J Wound Ostomy Continence Nurs 2006; 33: 26-29.
61. Kendler KS, Krakowski LM, Prescott CA.Fears and phobias: reliability and heritability.Psychol Med 1999; 29: 539-553.